RCA In-Ear vs ReSound OMNIA miniRIE
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

RCA In-Ear
The RCA In-Ear is a budget-priced OTC hearing aid available for $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC hearing aid category, ranking 64th out of 65 devices tested. In our standardized testing, the RCA In-Ear shows a mixed performance profile. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users are unlikely to experience whistling or squealing during normal wear. Own-voice comfort scores 2.6/5, which is essentially at the category average (+0.09 points), offering mixed but acceptable performance for how your own voice sounds while wearing the devices. However, the core speech performance metrics present significant limitations. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, and speech in noise also scores 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio entertainment purposes. At this price point, buyers have considerably stronger options. Competitors like the Lucid Enrich Pro and JLab Hear OTC offer better sound performance at lower prices. The RCA In-Ear may appeal to those prioritizing feedback-free wear above speech clarity, but most users seeking meaningful hearing benefit should consider higher-performing alternatives in this budget segment.
Choice

ReSound OMNIA miniRIE
The ReSound OMNIA miniRIE is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,764. In our lab testing, it earned a SoundScore of 4.0/5 (A grade), ranking #26 of 39 prescription hearing aids tested. This device demonstrates solid speech clarity in quiet environments, scoring 3.7/5—0.26 points above the category average. Own-voice comfort also measures slightly above average at 2.9/5. However, the OMNIA miniRIE struggles in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, which is 1.11 points below the category average and low in absolute terms. This represents a significant limitation for users who frequently encounter noisy environments like restaurants or social gatherings. Feedback handling is strong in absolute terms at 4.1/5, though this falls 0.62 points below the prescription hearing aid category average of 4.72/5. Music streaming performance is mixed at 2.7/5, essentially matching the category average. The device offers modern connectivity features including iPhone and Android streaming, hands-free calling, and rechargeable batteries. While the OMNIA miniRIE has earned Expert's Choice Awards in 2023 and 2024, consumers in this premium price tier should note that several competitors—including the Phonak Sphere Infinio and Oticon Intent—achieve higher overall scores. This hearing aid may be best suited for individuals who prioritize performance in quieter settings and value ReSound's ecosystem, but those needing robust noise management should explore alternatives.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit